Shows that the Amarantus product is legit. Why wou
Post# of 30028
They are advising the company on how to get the brand recognition across to other pharma's. That is why there testing Lympro vs Amyvid, which by the was the product Trzepacz was the medical lead at Lilly.
As far as rev's, right now we are testing the market. Right now companies are getting prepared to start Phase 2 and 3 for Alz. Other companies are doing behind the scene DD with Lympro on small test subjects. Once they pass the quality test on the small # of subject they can expand it to more patients.
You know the company has much promise. It's a matter for time when the pps will reflect the companies true value.
Let's get off the OTC and get the capital raise done.